Galmed Pharmaceuticals Extends Aramchol's Patent Protection to 2039 for NASH Therapy Enhancement Galmed Pharmaceuticals has secured a new patent for Aramchol, extending its protection to 2039. This move enhances its position in the NASH treatment landscape and supports the development of combination therapies.

Galmed Pharmaceuticals Extends Aramchol's Patent Protection to 2039 for NASH Therapy Enhancement #Israel #Tel_Aviv #Galmed_Pharmaceuticals #Aramchol #NASH_Therapy